Benzinga | Oct 20, 2020 04:09PM EDT

Apyx Medical Reports 2 Peer-Reviewed Clinical Publications Evaluating Renuvion's Helium Plasma Technology

Apyx Medical Corporation (NASDAQ:APYX) (the "Company"), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion(r) in the cosmetic surgery market and J-Plasma(r) in the hospital surgical market, today announced the publication of two separate peer-reviewed articles published in the journal, Dermatological Reviews.

"We are very pleased to announce these two peer-reviewed clinical publications, which represent important additions to the portfolio of clinical evidence supporting the use of Renuvion," said Charlie Goodwin, President and Chief Executive Officer. "Specifically, these publications looked retrospectively at the use of Renuvion when used independently of liposuction for subdermal coagulation in the neck and when used in combination with liposuction for subdermal coagulation in various treatment areas of the body. The data from the retrospective studies in these publications serves to strengthen the risk/benefit profile of Renuvion's Helium Plasma Technology. Building on the results of these studies, we look forward to the continued expansion of our portfolio of clinical evidence to demonstrate the clinical utility of our Renuvion technology and facilitate broad-based adoption in the market."

The peer-reviewed clinical publications are:

"A Retrospective Chart Review of Subdermal Neck Coagulation Using Helium Plasma Technology"

This journal article consisted of two separate retrospective chart review studies (Study 1, n=15 and Study 2, n= 13) performed using data from subjects who had undergone helium plasma treatment with Renuvion for subdermal coagulation to achieve tissue contraction in the neck.

Article citation: Doolabh V, Ruff P. A Retrospective Chart Review of Subdermal Neck Coagulation Using Helium Plasma Technology. Dermatological Reviews. 2020;1--8. https://doi.org/10.1002/der2.32

"Safety and Efficacy of Helium Plasma for Subdermal Coagulation"

This journal article consisted of two separate retrospective chart review studies (Study 1, n= 37 and Study 2, n= 148) performed using data from subjects who had undergone liposuction followed by subdermal coagulation using Renuvion. Subjects were treated in a variety of anatomical areas, such as the abdomen, arms, and neck.

Article citation: Ruff PG, Doolabh V, Zimmerman EM, Gentile RA. Safety and efficacy of helium plasma for subdermal coagulation. Dermatological Reviews. 2020;1--7. https://doi.org/10.1002/der2.34